◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0575

Regent Pacific Group Limited (0575) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Regent Pacific Group Limited (0575) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 16 employees. Its market capitalization is roughly $271 million. In the fiscal year ended 2025-12-31, 0575 reported $0M in revenue and ($5M) in net income.

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment.

Interactive charts & full statements →

0575 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$1M$0M$0M
Gross Profit($2M)($2M)($3M)($0M)
Operating Income (EBIT)($4M)($4M)($28M)($31M)
Net Income($5M)($4M)($25M)($36M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0575 Free Cash Flow History

0575 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1M$1M$3M$26M
Total Liabilities$7M$6M$4M$24M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0575 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← 0574All “0-9” companies0576 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.